HZO Stock Analysis: MarineMax | NYSE
Specialty Retail | NYSE, USA | Market Cap: 1.167m USD | 12M Return: 133.5% | US5679081084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 37.9M
EPS Trend: -92.6%
Qual. Beats: 0
Rev. Trend: -90.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
MarineMax, Inc. (NYSE: HZO) is a U.S.-based recreational boat and yacht retailer and superyacht services company headquartered in Oldsmar, Florida, operating through two segments: Retail Operations and Product Manufacturing. The company sells a wide range of new and used recreational vessels-from fishing boats and pontoons to mega-yachts and e-power yachts-and offers marine parts, accessories, engines, maintenance, repair, slip and storage services, brokerage, yacht charters, and boat/yacht finance and insurance products. It also manufactures and sells sport yachts and yachts, operates MarineMax vacations in Tortola and the British Virgin Islands, and markets through offsite locations and print catalogs. The company was incorporated in 1998.
As a small-cap stock in the Consumer Discretionary sector (Other Specialty Retail sub-industry), MarineMax combines a traditional specialty retail model with vertically integrated manufacturing and service offerings, including in-house yacht production and charter operations. Its Florida base and Caribbean vacation business position it within key U.S. recreational boating markets, while its finance and insurance arms allow it to capture additional revenue streams beyond the initial boat sale.
- Used boat inventory glut pressures retail segment margins
- Federal rate cuts stimulate boat financing demand
- Superyacht services revenue grows with HNW travel
| Net Income: -8.20m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.03 > 1.0 |
| NWC/Revenue: 8.07% < 20% (prev 8.49%; Δ -0.42% < -1%) |
| CFO/TA 0.03 > 3% & CFO 72.8m > Net Income -8.20m |
| Net Debt (1.09b) to EBITDA (51.3m): 21.21 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.0m) vs 12m ago 2.63% < -2% |
| Gross Margin: 34.85% > 18% (prev 32.49%; Δ 2.36% > 0.5%) |
| Asset Turnover: 89.99% > 50% (prev 93.48%; Δ -3.49% > 0%) |
| Interest Coverage Ratio: 0.88 > 6 (EBIT TTM 51.3m / Interest Expense TTM 58.0m) |
| A: 0.07 (Total Current Assets 1.08b - Total Current Liabilities 902.0m) / Total Assets 2.34b |
| B: 0.32 (Retained Earnings 738.2m / Total Assets 2.34b) |
| C: 0.02 (EBIT TTM 51.3m / Avg Total Assets 2.40b) |
| D: 0.67 (Book Value of Equity 933.6m / Total Liabilities 1.39b) |
| Altman-Z'' = 2.37 = BBB |
| DSRI: 0.77 (Receivables 78.5m/108.3m, Revenue 2.16b/2.31b) |
| GMI: 0.93 (GM 32.49% / 34.85%) |
| AQI: 1.05 (AQ_t 0.25 / AQ_t-1 0.24) |
| SGI: 0.94 (Revenue 2.16b / 2.31b) |
| TATA: -0.03 (NI -8.20m - CFO 72.8m) / TA 2.34b) |
| Beneish M = -3.29 (Cap -4..+1) = AA |
As of November 19, 2026, the stock is trading at USD 52.85 with a total of 927,603 shares traded. Over the past week, the price has changed by +0.11%, over one month by +1.62%, over three months by +1.28% and over the past year by +133.54%.
Current recommended Stop Loss: 52.40 (which is 0.9% or 3.5 ATR below the current price).
MarineMax has received a consensus analysts rating of 3.22. Therefore, it is recommended to hold HZO.
- StrongBuy: 1
- Buy: 0
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 49.4 | -6.5% |
P/E Forward = 34.7222
P/S = 0.5392
P/B = 1.2493
P/EG = 1.0885
Revenue TTM = 2.16b USD
EBIT TTM = 51.3m USD
EBITDA TTM = 51.3m USD
Long Term Debt = 335.2m USD (from longTermDebt, two quarters ago)
Short Term Debt = 656.2m USD (from shortTermDebt, last quarter)
Debt = 1.24b USD (from shortLongTermDebtTotal, last quarter) + Leases 138.8m
Net Debt = 1.09b USD (calculated: Debt 1.24b - CCE 156.4m)
Enterprise Value = 2.25b USD (1.17b + Debt 1.24b - CCE 156.4m)
Interest Coverage Ratio = 0.88 (Ebit TTM 51.3m / Interest Expense TTM 58.0m)
EV/FCF = 188.7x (Enterprise Value 2.25b / FCF TTM 11.9m)
FCF Yield = 0.53% (FCF TTM 11.9m / Enterprise Value 2.25b)
FCF Margin = 0.55% (FCF TTM 11.9m / Revenue TTM 2.16b)
Net Margin = -0.38% (Net Income TTM -8.20m / Revenue TTM 2.16b)
Gross Margin = 34.85% ((Revenue TTM 2.16b - Cost of Revenue TTM 1.41b) / Revenue TTM)
Gross Margin QoQ = 37.36% (prev 35.68%)
Tobins Q-Ratio = 0.96 (Enterprise Value 2.25b / Total Assets 2.34b)
Interest Expense / Debt = 4.67% (Interest Expense 58.0m / Debt 1.24b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 40.5m (EBIT 51.3m * (1 - 21.00%))
Current Ratio = 1.19 (Total Current Assets 1.08b / Total Current Liabilities 902.0m)
Debt / Equity = 1.33 (Debt 1.24b / totalStockholderEquity, last quarter 933.6m)
Debt / EBITDA = 21.21 (Net Debt 1.09b / EBITDA 51.3m)
Debt / FCF = 91.02 (Net Debt 1.09b / FCF TTM 11.9m)
Total Stockholder Equity = 937.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.34% (Net Income -8.20m / Total Assets 2.34b)
RoE = -0.87% (Net Income TTM -8.20m / Total Stockholder Equity 937.8m)
RoCE = 4.03% (EBIT 51.3m / Capital Employed (Equity 937.8m + L.T.Debt 335.2m))
RoIC = 2.04% (NOPAT 40.5m / Invested Capital 1.98b)
WACC = 6.86% (E(1.17b)/V(2.41b) * Re(10.25%) + D(1.24b)/V(2.41b) * Rd(4.67%) * (1-Tc(0.21)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -55.49 | Cagr: -1.99%
[DCF] Terminal Value 75.44% ; FCFF base≈11.9m ; Y1≈12.0m ; Y5≈12.7m
[DCF] Fair Price = N/A (negative equity: EV 197.6m - Net Debt 1.09b = -889.4m; debt exceeds intrinsic value)
EPS Correlation: -92.56 | EPS CAGR: -58.79% | SUE: -0.33 | # QB: 0
Revenue Correlation: -90.63 | Revenue CAGR: -4.19% | SUE: -0.63 | # QB: 0
EPS current Quarter (2026-12-31): EPS=-0.00 | Chg30d=N/A | Revisions=+25% | Analysts=5
EPS next Quarter (2027-03-31): EPS=0.25 | Chg30d=+2.42% | Revisions=-25% | Analysts=5
EPS current Year (2027-09-30): EPS=1.46 | Chg30d=-7.43% | Revisions=-40% | GrowthEPS=+151.3% | GrowthRev=+4.0%
EPS next Year (2028-09-30): EPS=2.56 | Chg30d=-0.48% | Revisions=-25% | GrowthEPS=+75.7% | GrowthRev=+6.8%
[Analyst] Revisions Ratio: -38% (up=1, down=4)